Re: OTC Trading questions
|
3
|
Zenith Epigenetics
|
Mar 09, 2022 12:12PM
|
Re: Our own BKC on the webcast
|
9
|
Resverlogix Corp.
|
Feb 18, 2021 04:01PM
|
Re: Our own BKC on the webcast
|
13
|
Resverlogix Corp.
|
Feb 05, 2021 01:04PM
|
Re: Our own BKC on the webcast
|
9
|
Resverlogix Corp.
|
Feb 19, 2021 12:40PM
|
Re: Over 700K traded in Canada today....
|
3
|
Resverlogix Corp.
|
Oct 25, 2019 05:35PM
|
Re: Ownership Update
|
5
|
Resverlogix Corp.
|
Feb 21, 2023 09:29AM
|
Re: P3
|
3
|
Resverlogix Corp.
|
Jun 19, 2015 08:08AM
|
Re: Pascal Soriot
|
5
|
Resverlogix Corp.
|
Jul 13, 2017 10:37AM
|
Re: Perspective...the yo-yo on the escalator
|
2
|
Resverlogix Corp.
|
Dec 29, 2015 06:39PM
|
Re: PFE "is only the start of the spending spree that the company has planned"maybe,just maybe
|
7
|
Resverlogix Corp.
|
May 11, 2022 02:19PM
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
3
|
Resverlogix Corp.
|
Mar 11, 2021 11:36AM
|
Re: Phase 3 - Fall Start
|
1
|
Resverlogix Corp.
|
Jun 22, 2015 11:56AM
|
Re: Phase 3 Status with a European Regulatory Authority
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 08:45AM
|
Re: Phase III approval rates....
|
4
|
Resverlogix Corp.
|
Jul 12, 2015 03:08PM
|
Re: Placebo or Standard of Care
|
1
|
Resverlogix Corp.
|
Nov 02, 2019 05:47PM
|
Re: Placebo or Standard of Care
|
|
Resverlogix Corp.
|
Nov 02, 2019 06:03PM
|
Re: Pointing in the right direction & bogus Lilly
|
5
|
Resverlogix Corp.
|
Jun 21, 2018 10:32AM
|
Re: Positives & negatives
|
5
|
Resverlogix Corp.
|
Sep 17, 2015 10:43AM
|
Re: Positives & negatives
|
4
|
Resverlogix Corp.
|
Sep 16, 2015 12:57PM
|
Re: Positives & negatives
|
3
|
Resverlogix Corp.
|
Sep 16, 2015 03:35PM
|